Impact of Simulated Gastrointestinal Conditions on Antiglycoxidant and α-Glucosidase Inhibition Capacities of Cyanidin-3-<i>O</i>-Glucoside

Cyanidin-3-<i>O</i>-glucoside (C3G) is a widespread anthocyanin derivative, which has been reported in vitro to exert potent antioxidant, antiglycation and α-glucosidase inhibition effects. Nevertheless, the physiological relevance of such properties remains uncertain considering its sig...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Didier Fraisse, Alexis Bred, Catherine Felgines, François Senejoux
Formato: article
Lenguaje:EN
Publicado: MDPI AG 2021
Materias:
Acceso en línea:https://doaj.org/article/4c9c026b82cc449a9dfb7221a92a47b1
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:4c9c026b82cc449a9dfb7221a92a47b1
record_format dspace
spelling oai:doaj.org-article:4c9c026b82cc449a9dfb7221a92a47b12021-11-25T16:25:46ZImpact of Simulated Gastrointestinal Conditions on Antiglycoxidant and α-Glucosidase Inhibition Capacities of Cyanidin-3-<i>O</i>-Glucoside10.3390/antiox101116702076-3921https://doaj.org/article/4c9c026b82cc449a9dfb7221a92a47b12021-10-01T00:00:00Zhttps://www.mdpi.com/2076-3921/10/11/1670https://doaj.org/toc/2076-3921Cyanidin-3-<i>O</i>-glucoside (C3G) is a widespread anthocyanin derivative, which has been reported in vitro to exert potent antioxidant, antiglycation and α-glucosidase inhibition effects. Nevertheless, the physiological relevance of such properties remains uncertain considering its significant instability in gastrointestinal conditions. A simulated digestion procedure was thus instigated to assess the influence of gastric and intestinal media on its chemical integrity and biological activities. HPLC analyses of digested C3G samples confirmed the striking impact of intestinal conditions, as attested by a decomposition ratio of 70%. In contrast, with recovery rates of around 90%, antiglycation, as well as DPPH and ABTS scavenging assays, uniformly revealed a noteworthy persistence of its antiglycoxidant capacities. Remarkably, a prominent increase of its α-glucosidase inhibition activity was even observed after the intestinal phase, suggesting that classical in vitro evaluations might underestimate C3G antidiabetic potential. Consequently, the present data provide novel and specific insights on C3G’s digestive fate, suggesting that the gastrointestinal tract does not profoundly affect its positive action on oxidative and carbonyl stresses. More specifically, it also tends to support its regulating effects on postprandial hyperglycemia and its potential usefulness for diabetes management.Didier FraisseAlexis BredCatherine FelginesFrançois SenejouxMDPI AGarticlecyanidin-3-<i>O</i>-glucosidekuromaninanthocyaninantioxidantglycationglucosidaseTherapeutics. PharmacologyRM1-950ENAntioxidants, Vol 10, Iss 1670, p 1670 (2021)
institution DOAJ
collection DOAJ
language EN
topic cyanidin-3-<i>O</i>-glucoside
kuromanin
anthocyanin
antioxidant
glycation
glucosidase
Therapeutics. Pharmacology
RM1-950
spellingShingle cyanidin-3-<i>O</i>-glucoside
kuromanin
anthocyanin
antioxidant
glycation
glucosidase
Therapeutics. Pharmacology
RM1-950
Didier Fraisse
Alexis Bred
Catherine Felgines
François Senejoux
Impact of Simulated Gastrointestinal Conditions on Antiglycoxidant and α-Glucosidase Inhibition Capacities of Cyanidin-3-<i>O</i>-Glucoside
description Cyanidin-3-<i>O</i>-glucoside (C3G) is a widespread anthocyanin derivative, which has been reported in vitro to exert potent antioxidant, antiglycation and α-glucosidase inhibition effects. Nevertheless, the physiological relevance of such properties remains uncertain considering its significant instability in gastrointestinal conditions. A simulated digestion procedure was thus instigated to assess the influence of gastric and intestinal media on its chemical integrity and biological activities. HPLC analyses of digested C3G samples confirmed the striking impact of intestinal conditions, as attested by a decomposition ratio of 70%. In contrast, with recovery rates of around 90%, antiglycation, as well as DPPH and ABTS scavenging assays, uniformly revealed a noteworthy persistence of its antiglycoxidant capacities. Remarkably, a prominent increase of its α-glucosidase inhibition activity was even observed after the intestinal phase, suggesting that classical in vitro evaluations might underestimate C3G antidiabetic potential. Consequently, the present data provide novel and specific insights on C3G’s digestive fate, suggesting that the gastrointestinal tract does not profoundly affect its positive action on oxidative and carbonyl stresses. More specifically, it also tends to support its regulating effects on postprandial hyperglycemia and its potential usefulness for diabetes management.
format article
author Didier Fraisse
Alexis Bred
Catherine Felgines
François Senejoux
author_facet Didier Fraisse
Alexis Bred
Catherine Felgines
François Senejoux
author_sort Didier Fraisse
title Impact of Simulated Gastrointestinal Conditions on Antiglycoxidant and α-Glucosidase Inhibition Capacities of Cyanidin-3-<i>O</i>-Glucoside
title_short Impact of Simulated Gastrointestinal Conditions on Antiglycoxidant and α-Glucosidase Inhibition Capacities of Cyanidin-3-<i>O</i>-Glucoside
title_full Impact of Simulated Gastrointestinal Conditions on Antiglycoxidant and α-Glucosidase Inhibition Capacities of Cyanidin-3-<i>O</i>-Glucoside
title_fullStr Impact of Simulated Gastrointestinal Conditions on Antiglycoxidant and α-Glucosidase Inhibition Capacities of Cyanidin-3-<i>O</i>-Glucoside
title_full_unstemmed Impact of Simulated Gastrointestinal Conditions on Antiglycoxidant and α-Glucosidase Inhibition Capacities of Cyanidin-3-<i>O</i>-Glucoside
title_sort impact of simulated gastrointestinal conditions on antiglycoxidant and α-glucosidase inhibition capacities of cyanidin-3-<i>o</i>-glucoside
publisher MDPI AG
publishDate 2021
url https://doaj.org/article/4c9c026b82cc449a9dfb7221a92a47b1
work_keys_str_mv AT didierfraisse impactofsimulatedgastrointestinalconditionsonantiglycoxidantandaglucosidaseinhibitioncapacitiesofcyanidin3ioiglucoside
AT alexisbred impactofsimulatedgastrointestinalconditionsonantiglycoxidantandaglucosidaseinhibitioncapacitiesofcyanidin3ioiglucoside
AT catherinefelgines impactofsimulatedgastrointestinalconditionsonantiglycoxidantandaglucosidaseinhibitioncapacitiesofcyanidin3ioiglucoside
AT francoissenejoux impactofsimulatedgastrointestinalconditionsonantiglycoxidantandaglucosidaseinhibitioncapacitiesofcyanidin3ioiglucoside
_version_ 1718413197993574400